Lovastatin increases the risk of myopathy and:

A) hyperglycemia
B) hyperlipidemia
C) rhabdomyolysis
D) hypertension

C) rhabdomyolysis
Lovastatin increases the risk of myopathy and rhabdomyolysis. It may also increase repaglinide levels and duration of action. Lovastatin is sold under the trade names AltoprevĀ® and MevacorĀ®.

Health Professions

You might also like to view...

Which of the following NIV settings produces the greatest tidal volume, with all other variables being equal (i.e., airway resistance and lung compliance)?

a. IPAP = 20 cm H2O; EPAP = 8 cm H2O b. IPAP = 15 cm H2O; EPAP = 5 cm H2O c. IPAP = 12 cm H2O; EPAP = 6 cm H2O d. IPAP = 18 cm H2O; EPAP = 4 cm H2O

Health Professions

Detachment at left femoral region, open approach

A) 0Y630ZZ B) 0Y640ZZ C) 0Y670ZZ D) 0Y680ZZ

Health Professions